EpiVax Oncology, Inc.

New Filing
CIK: 0001724741·Biotechnology·DELAWARE·Filed: Oct 7, 2019
Total Offering

$1,250,000

Amount Sold

$375,000

Investors

5

First Sale

Aug 27, 2019

Offering Details

Type
Debt, Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2017
Non-Accredited Investors
No

Related Persons

NameRole
Gad Berdugo
Related Person
William Martin
Related Person
Clifford Grimm
Related Person
Anne De Groot
Related Person
Daniel Adams
Related Person

Company

EpiVax Therapeutics, Inc.

180 Varick Street

New York, NY, 10014

6469122525

SEC Filing

0001724741-19-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
EpiVax Oncology, Inc. Form D Filing — $1,250,000 | FilingFlow